HEADER TRANSFERASE/TRANSFERASE INHIBITOR 19-AUG-13 4MBL TITLE DISCOVERY OF PYRAZOLO[1,5A]PYRIMIDINE-BASED PIM1 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PIM-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 120-404; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PIM1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 STAR KEYWDS KINASE, PIM1, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.AZEVEDO,T.O.FISCHMANN REVDAT 3 28-FEB-24 4MBL 1 REMARK SEQADV REVDAT 2 30-OCT-13 4MBL 1 JRNL REVDAT 1 11-SEP-13 4MBL 0 JRNL AUTH M.P.DWYER,K.KEERTIKAR,K.PARUCH,C.ALVAREZ,M.LABROLI,C.POKER, JRNL AUTH 2 T.O.FISCHMANN,R.MAYER-EZELL,R.BOND,Y.WANG,R.AZEVEDO,T.J.GUZI JRNL TITL DISCOVERY OF PYRAZOLO[1,5-A]PYRIMIDINE-BASED PIM INHIBITORS: JRNL TITL 2 A TEMPLATE-BASED APPROACH. JRNL REF BIOORG.MED.CHEM.LETT. V. 23 6178 2013 JRNL REFN ISSN 0960-894X JRNL PMID 24091081 JRNL DOI 10.1016/J.BMCL.2013.08.110 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.36 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 13778 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1388 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.81 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.97 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2803 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2241 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2518 REMARK 3 BIN R VALUE (WORKING SET) : 0.2169 REMARK 3 BIN FREE R VALUE : 0.2868 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.17 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 285 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2230 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 56.52 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.03040 REMARK 3 B22 (A**2) : -3.03040 REMARK 3 B33 (A**2) : 6.06080 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.354 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.914 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.876 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4496 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8102 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 974 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 58 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 666 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4496 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 279 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4827 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.27 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.61 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MBL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1000081708. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 8.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54180 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13800 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 38.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.14700 REMARK 200 R SYM (I) : 0.08300 REMARK 200 FOR THE DATA SET : 13.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.76300 REMARK 200 R SYM FOR SHELL (I) : 0.73800 REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10.5% PEG 400, 0.05 M TRIS-CL PH 8.4, REMARK 280 0.3 M NACL, 0.01 M DTT, 0.01M EDTA , VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.90600 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 26.95300 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 40.42950 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 13.47650 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 67.38250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 29 REMARK 465 GLU A 30 REMARK 465 LYS A 31 REMARK 465 GLU A 32 REMARK 465 LEU A 307 REMARK 465 SER A 308 REMARK 465 PRO A 309 REMARK 465 GLY A 310 REMARK 465 PRO A 311 REMARK 465 SER A 312 REMARK 465 LYS A 313 REMARK 465 VAL A 314 REMARK 465 GLU A 315 REMARK 465 HIS A 316 REMARK 465 HIS A 317 REMARK 465 HIS A 318 REMARK 465 HIS A 319 REMARK 465 HIS A 320 REMARK 465 HIS A 321 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 34 158.30 64.02 REMARK 500 ASP A 60 24.74 -153.29 REMARK 500 ASN A 61 25.55 48.93 REMARK 500 ASP A 167 54.64 -152.67 REMARK 500 ASP A 186 87.23 61.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 26L A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4MBI RELATED DB: PDB DBREF 4MBL A 29 313 UNP P11309 PIM1_HUMAN 120 404 SEQADV 4MBL VAL A 314 UNP P11309 EXPRESSION TAG SEQADV 4MBL GLU A 315 UNP P11309 EXPRESSION TAG SEQADV 4MBL HIS A 316 UNP P11309 EXPRESSION TAG SEQADV 4MBL HIS A 317 UNP P11309 EXPRESSION TAG SEQADV 4MBL HIS A 318 UNP P11309 EXPRESSION TAG SEQADV 4MBL HIS A 319 UNP P11309 EXPRESSION TAG SEQADV 4MBL HIS A 320 UNP P11309 EXPRESSION TAG SEQADV 4MBL HIS A 321 UNP P11309 EXPRESSION TAG SEQRES 1 A 293 LYS GLU LYS GLU PRO LEU GLU SER GLN TYR GLN VAL GLY SEQRES 2 A 293 PRO LEU LEU GLY SER GLY GLY PHE GLY SER VAL TYR SER SEQRES 3 A 293 GLY ILE ARG VAL SER ASP ASN LEU PRO VAL ALA ILE LYS SEQRES 4 A 293 HIS VAL GLU LYS ASP ARG ILE SER ASP TRP GLY GLU LEU SEQRES 5 A 293 PRO ASN GLY THR ARG VAL PRO MET GLU VAL VAL LEU LEU SEQRES 6 A 293 LYS LYS VAL SER SER GLY PHE SER GLY VAL ILE ARG LEU SEQRES 7 A 293 LEU ASP TRP PHE GLU ARG PRO ASP SER PHE VAL LEU ILE SEQRES 8 A 293 LEU GLU ARG PRO GLU PRO VAL GLN ASP LEU PHE ASP PHE SEQRES 9 A 293 ILE THR GLU ARG GLY ALA LEU GLN GLU GLU LEU ALA ARG SEQRES 10 A 293 SER PHE PHE TRP GLN VAL LEU GLU ALA VAL ARG HIS CYS SEQRES 11 A 293 HIS ASN CYS GLY VAL LEU HIS ARG ASP ILE LYS ASP GLU SEQRES 12 A 293 ASN ILE LEU ILE ASP LEU ASN ARG GLY GLU LEU LYS LEU SEQRES 13 A 293 ILE ASP PHE GLY SER GLY ALA LEU LEU LYS ASP THR VAL SEQRES 14 A 293 TYR THR ASP PHE ASP GLY THR ARG VAL TYR SER PRO PRO SEQRES 15 A 293 GLU TRP ILE ARG TYR HIS ARG TYR HIS GLY ARG SER ALA SEQRES 16 A 293 ALA VAL TRP SER LEU GLY ILE LEU LEU TYR ASP MET VAL SEQRES 17 A 293 CYS GLY ASP ILE PRO PHE GLU HIS ASP GLU GLU ILE ILE SEQRES 18 A 293 ARG GLY GLN VAL PHE PHE ARG GLN ARG VAL SER SER GLU SEQRES 19 A 293 CYS GLN HIS LEU ILE ARG TRP CYS LEU ALA LEU ARG PRO SEQRES 20 A 293 SER ASP ARG PRO THR PHE GLU GLU ILE GLN ASN HIS PRO SEQRES 21 A 293 TRP MET GLN ASP VAL LEU LEU PRO GLN GLU THR ALA GLU SEQRES 22 A 293 ILE HIS LEU HIS SER LEU SER PRO GLY PRO SER LYS VAL SEQRES 23 A 293 GLU HIS HIS HIS HIS HIS HIS HET 26L A 401 27 HETNAM 26L (1R,2R)-N-[3-(NAPHTHALEN-2-YL)PYRAZOLO[1,5-A]PYRIMIDIN- HETNAM 2 26L 5-YL]CYCLOHEXANE-1,2-DIAMINE FORMUL 2 26L C22 H23 N5 HELIX 1 1 ASP A 72 ILE A 74 5 3 HELIX 2 2 MET A 88 SER A 97 1 10 HELIX 3 3 LEU A 129 GLY A 137 1 9 HELIX 4 4 GLN A 140 CYS A 161 1 22 HELIX 5 5 LYS A 169 GLU A 171 5 3 HELIX 6 6 THR A 204 SER A 208 5 5 HELIX 7 7 PRO A 209 HIS A 216 1 8 HELIX 8 8 HIS A 219 GLY A 238 1 20 HELIX 9 9 HIS A 244 GLY A 251 1 8 HELIX 10 10 SER A 260 LEU A 271 1 12 HELIX 11 11 ARG A 274 ARG A 278 5 5 HELIX 12 12 THR A 280 ASN A 286 1 7 HELIX 13 13 HIS A 287 GLN A 291 5 5 HELIX 14 14 LEU A 295 LEU A 304 1 10 SHEET 1 A 5 TYR A 38 GLY A 47 0 SHEET 2 A 5 GLY A 50 ARG A 57 -1 O VAL A 52 N GLY A 45 SHEET 3 A 5 PRO A 63 GLU A 70 -1 O VAL A 64 N GLY A 55 SHEET 4 A 5 SER A 115 GLU A 121 -1 O PHE A 116 N VAL A 69 SHEET 5 A 5 LEU A 106 GLU A 111 -1 N PHE A 110 O VAL A 117 SHEET 1 B 2 TRP A 77 GLU A 79 0 SHEET 2 B 2 ARG A 85 PRO A 87 -1 O VAL A 86 N GLY A 78 SHEET 1 C 3 VAL A 126 ASP A 128 0 SHEET 2 C 3 ILE A 173 ASP A 176 -1 O ILE A 175 N GLN A 127 SHEET 3 C 3 GLU A 181 LEU A 184 -1 O LYS A 183 N LEU A 174 SHEET 1 D 2 VAL A 163 LEU A 164 0 SHEET 2 D 2 ALA A 191 LEU A 192 -1 O ALA A 191 N LEU A 164 CISPEP 1 GLY A 99 PHE A 100 0 3.17 CISPEP 2 GLU A 124 PRO A 125 0 -1.29 SITE 1 AC1 7 PHE A 49 ALA A 65 LYS A 67 ASP A 128 SITE 2 AC1 7 GLU A 171 LEU A 174 ASP A 186 CRYST1 98.560 98.560 80.859 90.00 90.00 120.00 P 65 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010146 0.005858 0.000000 0.00000 SCALE2 0.000000 0.011716 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012367 0.00000